SBIR/STTR Research Award

Low-cost custom microarray synthesis

Award identifier 45339136953832f9de6972301ee89725d64787564c89678fd69e2ba4463023fbAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$290,030

Program and phase

STTR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIODISCOVERY LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
LBLFVDY5RK61
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): In this project our goal is to develop and commercialize a very low cost microarray chip fabrication technology to reduce the cost by as much as a factor of ten and enable the use of microarrays by groups who can not afford the current generation of microarrays. Our technology combines the standard acid labile DMT protection group containing nucleophosphoramidite monomers with localized acid generation by projection lithography to in situ synthesize oligonucleotides and oligopeptides on simple substrates such as glass slides in a massively parallel fashion. To increase the use of microarrays further, decrease the cost of using them and simplifying the information read out, we will develop low tech oligonucleotide microarrays which can be read by the human eye, a flat bed scanner or a barcode reader for yes or no type diagnostic purposes. We will also demonstrate the production of low cost custom microarrays on glass slides containing more than 500,000 different oligonucleotides on a single slide. Combining the ease of a yes or no type of readout with our oligonuclotide design software and databases, we will make several demonstration slides for tracking common viruses, as well as bacteria such as the flu or tuberculosis. Finally we will also demonstrate 5'-->3' synthesis with high stepwise yield to show that our technology can also be used to produce PCR primers or oligonucleotide libraries for gene synthesis or studies of small molecule binding, drug discovery, etc. Our preliminary results show that all of the above aims are achievable within the time frame and budget proposed. DNA chips or microarrays are one of the primary tools by which predisposition towards certain diseases such as cancer, response of human body's defense mechanism to viruses and drugs are studied. However, cost of using microarrays is still quite high and is a barrier to their increased usage in diagnosis and in poorer environments. In this project, our goal is to produce microarrays that are much cheaper, as well as easier to use so that they can be used world-wide in tracking viruses, or disease diagnostics.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

7 SBIR/STTR records share this UEI (2006–2015). Reported award amounts total $3,287,520. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.